Growth Metrics

Calidi Biotherapeutics (CLDI) Capital Leases (2022 - 2025)

Calidi Biotherapeutics' quarterly Capital Leases came in at $171000.0 in Q4 2025, up 17.93% year-on-year from $145000.0 in Q4 2024, and down 13.2% quarter-over-quarter from $197000.0 in Q3 2025.

Calidi Biotherapeutics has reported Capital Leases for 4 years, with the latest figure at $171000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Capital Leases rose 17.93% year-over-year to $171000.0; the trailing twelve-month figure through Dec 2025 stood at $171000.0 (up 17.93% YoY), and the FY2025 full-year result was $171000.0, up 17.93% from the prior year.
  • Capital Leases for Q4 2025 stood at $171000.0, down from $197000.0 in the prior quarter.
  • The five-year high for Capital Leases was $226000.0 in Q2 2025, with the low at $65000.0 in Q3 2022.
  • Average Capital Leases over 4 years is $154714.3, with a median of $155500.0 recorded in 2024.
  • Year-over-year, Capital Leases surged 72.92% in 2024 and slumped 34.52% in 2025.
  • Tracing CLDI's Capital Leases over 4 years: stood at $142000.0 in 2022, then soared by 52.11% to $216000.0 in 2023, then slumped by 32.87% to $145000.0 in 2024, then rose by 17.93% to $171000.0 in 2025.
  • The last three Capital Leases figures came in at $171000.0 (Q4 2025), $197000.0 (Q3 2025), and $226000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn -
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn
8 Evaxion A 65.44 Bn 65.42 Bn -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn
10 Calidi Biotherapeutics - - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 171,000.00
Sep 30, 2025 197,000.00
Jun 30, 2025 226,000.00
Mar 31, 2025 129,000.00
Dec 31, 2024 145,000.00
Sep 30, 2024 166,000.00
Jun 30, 2024 180,000.00
Mar 31, 2024 197,000.00
Dec 31, 2023 216,000.00
Sep 30, 2023 96,000.00
Jun 30, 2023 110,000.00
Mar 31, 2023 126,000.00
Dec 31, 2022 142,000.00
Sep 30, 2022 65,000.00